No effect of garlic extract supplement on serum lipid levels in hypercholesterolemic subjects

Journal of the Medical Association of Thailand

Volumn 86, Issue 8, 2003, Pages 750-757

  Satitvipawee, Pratana ^a   Indrabhakti, Saowanin ^c   Getn Gern, Panisa ^d   Rawdaree, Petch ^b   Ratanasuwan, Tanaporn ^c   Viwatwongkasem, Chukiat ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b NAVAMINDRADHIRAJ UNIVERSITY   (Thailand)

^c LERDSIN GENERAL HOSPITAL   (Thailand)

^d MINISTRY OF PUBLIC HEALTH   (Thailand)

Author keywords

Allicin; Garlic Extract Supplement; Hypercholesterolemic Subjects; Serum Lipids

Indexed keywords

ALLICIN; CHOLESTEROL; GARLIC EXTRACT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; TRIACYLGLYCEROL;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; ENTERIC COATED TABLET; FAT INTAKE; FEMALE; GARLIC; HUMAN; HYPERCHOLESTEROLEMIA; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; TABLET; TREATMENT OUTCOME;

ADULT; ANTILIPEMIC AGENTS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; LIPIDS; MALE; MIDDLE AGED; SULFINIC ACIDS; TRIGLYCERIDES;

EID: 0141702030     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. The World Health Report 2002. Reducing risks, promoting healthy life. Geneva: World Health Organization; 2002: 47-98.
2. Verschuren WMM, Jacobs DR, Bloemberg BPM, et al. Serum total cholesterol and long-term coronary heart disease mortality in different cultures: Twenty five-year follow-up of the seven countries study. JAMA 1995; 274: 131-6.
3. Stamler JD, Wentworth D, Neaton JD. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screens of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 1986; 256: 2823-8.
4. Schaefer EJ, McNamara JR. Overview of the diagnostic and treatment of lipid disorders. In: Rifai N, Warnick GR. Dominiczak MH, ed. Handbook of lipoprotein Testing: AACC Press; 1997: 25-47.
5. Rahman K, Billington D. Dietary supplementation with aged garlic extract inhibits ADP-induced platelet aggregation in humans. J Nutr 2000; 130: 2662-5.
6. Neil A, Silagy C. Garlic: Its cardio-protective properties. Curr Opin Lipidol 1994: 5: 6- 10.
7. Jain AK, Vargas R, Gotzkowsky S, McMahon FG. Can garlic reduce levels of serum lipids? A controlled clinical study. Am J Med 1993; 94: 632-5.
8. Adler AJ, Holub BJ. Effect of garlic and fish oil supplementation on serum lipid and lipoprotein concentrations in hypercholesterolemic men. Am J Clin Nutr 1997; 65: 445-50.
9. Isaacsohn JL, Moser M, Stein EA, et al. Garlic powder and plasma lipids and lipoproteins. A multicenter, randomized, placebo-controlled trial. Arch Intern Med 1998; 158: 1189-94.
10. Simons LA. Balasubramaniam S, Konigsmark M, Parfitt A, Simons J, Peters W. On the effect of garlic on plasma lipids and lipoproteins in mild hypercholesterolemia. Atherosclerosis 1995; 113: 219-25.
11. The Expert Panel. Report of the National Cholesterol Education Program on detection, evaluation and treatment of high blood cholesterol in adults. Arch Intern Med 1988; 148: 36-69.
12. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem 1974; 20: 470-5.
13. Sampson EJ, Demer LM, Kreig AF. Faster enzymatic procedure for serum triglycerides. Clin Chem 1975; 21: 1983-5.
14. Hino K, Nakamura M, Nakanishi K, Manabe M. A new method for the homogeneous assay of serum HDL-cholesterol. Clin Chem 1996; 42: S298.
15. Friedewald W, Levy R, Fredrickson D. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, with use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
16. nd ed. Baltimore: Williams and Wilkins; 1996: 37-107.
17. Kleijnen J, Knipschild P, Riet GT. Garlic, onions and cardiovascular risk factors. A review of the evidence from human experiments with emphasis on commercially available preparations. Br J Clin Pharmac 1989; 28: 535-44.
18. Aye RD. Garlic preparations and processing. Cardiology in Practice 1989; 10 (Symposium suppl): 7-8.
19. Koscielny J, Klubendorf D, Latza R, et al. The antiatherosclerotic effect of Allium sativum. Atherosclerosis 1999; 144: 237-49.
20. Muller B. Analytical methods for standardization of fresh garlic and garlic powder preparations. Deutsche Apotheker Zeitung 1991: 131 (Suppl 24): 8-10.
21. Superko HR, Krauss RM. Garlic powder, effect on plasma lipids, postprandial lipemia, low-density lipoprotein particle size, high-density lipoprotein subclass distribution and lipoprotein (a). J Am Coll Cardiol 2000; 35: 321-6.
22. Neil HA, Silagy CA, Lancaster T, et al. Garlic powder in the treatment of moderate hyperlipidaemia : A controlled trial and meta-analysis. J R Coll Physicians Lond 1996; 30: 329-34.
23. Gardner CD, Chatterjee LM, Carlson JJ. The effect of a garlic preparation on plasma lipid levels in moderately hypercholesterolemic adults. Atherosclerosis 2001; 154: 213-20.
24. Kannar D, Wattanapenpaiboon N, Savige GS, Wahlqvist ML. Hypocholesterolemic effect of an enteric-coated garlic supplement. J Am Coll Nutri 2001; 20: 225-31.
25. Berthold HK, Sudhop T, Von Bergmann K. Effect of a garlic oil preparation on serum lipoproteins and cholesterol metabolism: A randomized controlled trial. JAMA 1998; 279: 1900-2.
26. Steiner M, Khan AH, Holbert D, Lin RIS. A double-blind crossover study in moderately hypercholesterolemic men that compared the effect of aged garlic extract and placebo administration on blood lipids. Am J Clin Nutr 1996; 64: 866-70.
27. Lau BHS. Suppression of LDL oxidation by garlic. J Nutr 2001; 131: 985s-8s.
28. Yeh YY, Yeh SM. Garlic reduces plasma lipids by inhibiting hepatic cholesterol and triacylglycerol synthesis. Lipids 1994; 29: 189-93.
29. "United States Pharmacopeia 24". Rockville: The United States Pharmacopeial Convention Inc, 2000: 1944-7.